Agenda Cardiovascular Atherosclerosis 2023

7 a.m.

Registration, Breakfast & View Exhibits

7:55 a.m.

Welcome and Introductions

David Cork, MD

Christopher Suhar, MD

8 a.m.

Advanced Hypertension Management

Luke Laffin, MD

8:40 a.m.

Obesity and Diabetic Pharmacotherapy - A Focus on GLP-1 Agonists: Are You Ready to Prescribe?

Samantha Harris, MD

9:20 a.m.

Evaluate Horrible Cholesterol, Lipoprotein A: Prevalence, Impact, and Novel Therapeutics

Norman Lepor, MD

9:45 a.m.

Panel Discussion/Q&A

10 a.m.

Break & View Exhibits

10:30 a.m.

Genetic Testing for Familial Hypercholesterolemia: When to Test, Whom to Test?

P. Bart Duell, MD

11:10 a.m.

New Concepts in Dyslipidemia: Dispelling 10 "Truths" About Lipids

Douglas Triffon, MD

11:50 a.m.

Non-HDL Targets for Risk Reduction

David Cork, MD

12:15 p.m.

Panel Discussion/Q&A

12:30 p.m.

Lunch Break

Non-CME Lunch Symposium Hosted by Amryt Pharmaceuticals

Juxtapid: The Only Oral Adjunct Treatment for Homozygous Familial Hypercholesterolemia (HoFH)

Eliot A. Brinton, MD, FAHA, FNLA, FACE

Past President, American Board of Clinical Lipidology

President, Utah Lipid Center

1:15 p.m.

Personalized Medicine and Genomics: The Future is Here

Evan Muse, MD

1:55 p.m.

Heart Failure Management for Primary Care and General Cardiologists: Which Therapy for Which Patient?

Rola Khedraki, MD

2:25 p.m.

Supplements in Primary and Secondary Prevention of ASCVD

Christopher Suhar, MD

2:45 p.m.

Panel Discussion/Q&A

3 p.m.

Break & View Exhibits

3:15 p.m.

Non-Invasive Coronary Evaluations: CT Coronary Artery Imaging Review

Austin Robinson, MD

3:40 p.m.

Nonalcoholic Fatty Liver Disease and its Contribution to CV Disease

Jennifer Au, MD

4:05 p.m.

Bio-Identical Hormones and Testosterone Supplementation

Sarah Dalhoumi, MD



4:30 p.m.

Panel Discussion/Q&A

4:45 p.m.

Adjourn

**Topics, times, and speakers are subject to change.

**All times listed are Pacific Time